Abstract
Background
Chronic kidney disease is a frequent complication following heart and combined heart–lung transplantation. The aim of this study was to analyse the outcome of a subsequent renal transplant in heart, lung and heart–lung transplantation recipients.
Methods
All heart, lung and heart–lung transplant recipients who received a subsequent renal transplant over a 27-year period in a national heart and lung transplant centre were included in this study.
Results
A total of 18 patients who had previously undergone heart (n = 6), lung (n = 7) and heart–lung (n = 5) transplantation received a renal transplant. The mean duration to development of end-stage kidney disease (ESKD) was 115 ± 45.9 months. The most common contributor to ESKD was calcineurin inhibitor nephrotoxicity. The 5-year patient survival and graft survival rates were 91.7 and 85.6%, respectively. The median creatinine level at the most recent follow-up was 123 μmol/L, IQR 90.8–147.5.
Conclusions
The overall outcome of renal transplantation following previous non-renal solid organ transplantation is excellent considering the medical complexity and co-morbidities of this patient population. Renal transplantation represents an important treatment option for ESKD in non-renal solid organ transplant recipients.
Similar content being viewed by others
References
McCauley J, Van Thiel DH, Starzl TE, Puschett JB (1990) Acute and chronic renal failure in liver transplantation. Nephron 55:121–128
Ojo AO, Held PJ, Port FK et al (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931–940
Yusen RD, Edwards LB, Kucheryavaya AY et al (2014) The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report—2014; focus theme: retransplantation. J Heart Lung Transplant 33:1009–1024
Lund LH, Edwards LB, Kucheryavaya AY et al (2014) The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report—2014; focus theme: retransplantation. J Heart Lung Transplant 33:996–1008
Cassuto JR, Reese PP, Sonnad S et al (2010) Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant 10:2502–2511
Coopersmith CM, Brennan DC, Miller B et al (2001) Renal transplantation following previous heart, liver, and lung transplantation: an 8-year single-center experience. Surgery 130:457–462
Gupta J, Amaral S, Mahle WT (2008) Renal transplantation after previous pediatric heart transplantation. J Heart Lung Transplant 27:217–221
Jayasena SD, Riaz A, Lewis CM et al (2001) Outcome in patients with end-stage renal disease following heart or heart–lung transplantation receiving peritoneal dialysis. Nephrol Dial Transplant 16:1681–1685
Lonze BE, Warren DS, Stewart ZA et al (2009) Kidney transplantation in previous heart or lung recipients. Am J Transplant 9:578–585
Otani S, Levvey BJ, Westall GP et al (2015) Long-term successful outcomes from kidney transplantation after lung and heart-lung transplantation. Ann Thorac Surg 99:1032–1038
Tarnow H, Herlenius G, Friman S et al (2006) Outcome of renal transplantation subsequent to liver, heart, or lung transplantation. Transplant Proc 38:2649–2650
Wilkinson AH, Cohen DJ (1999) Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 10:1136–1144
Bloom RD, Reese PP (2007) Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 18:3031–3041
Canver CC, Heisey DM, Nichols RD (2000) Acute renal failure requiring hemodialysis immediately after heart transplantation portends a poor outcome. J Cardiovasc Surg (Torino) 41:203–206
Nankivell BJ, Chapman JR, Bonovas G, Gruenewald SM (2004) Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation 77:1457–1459
Klein IH, Abrahams A, van Ede T et al (2002) Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation 73:732–736
Penninga L, Penninga EI, Moller CH, et al. (2013) Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev 5: CD008817
McGuire BM, Julian BA, Bynon JS Jr et al (2006) Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144:735–741
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
We have no funding sources for this study.
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent from all individual participants included in the study was waived due to the retrospective nature of the study.
Rights and permissions
About this article
Cite this article
Wong, L., Chee, Y.R., Healy, D.G. et al. Renal transplantation outcomes following heart and heart–lung transplantation. Ir J Med Sci 186, 1027–1032 (2017). https://doi.org/10.1007/s11845-016-1550-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-016-1550-3